US Patent 11905329 Anti-PD-1 antibodies and uses thereof
Patent 11905329 was granted and assigned to Jounce Therapeutics, Inc. on February, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 7, 2022
0
Date of Patent
February 20, 2024
0
Patent Applicant
Patent Application Number
17834237
0
Patent Citations
Patent Inventor Names
George Robert Mabry, III
0
Stephen Sazinsky
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11905329 Anti-PD-1 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
